Wedbush Cuts Earnings Estimates for Healthpeak Properties

Healthpeak Properties, Inc. (NYSE:DOC) – Research analysts at Wedbush decreased their Q3 2025 earnings per share (EPS) estimates for shares of Healthpeak Properties in a note issued to investors on Friday, April 11th. Wedbush analyst R. Anderson now anticipates that the real estate investment trust will post earnings of $0.46 per share for the quarter, down from their prior forecast of $0.47. Wedbush currently has a “Outperform” rating and a $24.00 price objective on the stock. The consensus estimate for Healthpeak Properties’ current full-year earnings is $1.86 per share. Wedbush also issued estimates for Healthpeak Properties’ Q4 2025 earnings at $0.47 EPS, Q1 2026 earnings at $0.48 EPS, Q2 2026 earnings at $0.49 EPS, Q3 2026 earnings at $0.49 EPS and Q4 2026 earnings at $0.50 EPS.

Several other research analysts have also recently weighed in on DOC. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a research note on Wednesday, January 15th. StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Monday. Scotiabank cut their price target on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a report on Friday, February 28th. Finally, Robert W. Baird decreased their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Tuesday, February 11th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $23.83.

Healthpeak Properties Stock Performance

DOC opened at $18.77 on Monday. Healthpeak Properties has a 12-month low of $17.33 and a 12-month high of $23.26. The company has a market cap of $13.13 billion, a price-to-earnings ratio of 53.62, a PEG ratio of 2.17 and a beta of 1.02. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The company’s 50 day moving average is $19.74 and its 200 day moving average is $20.76.

Healthpeak Properties Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Friday, June 27th. Investors of record on Monday, June 16th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $1.22 dividend on an annualized basis and a yield of 6.50%. Healthpeak Properties’s dividend payout ratio is presently 348.57%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DOC. Mizuho Bank Ltd. purchased a new position in shares of Healthpeak Properties in the fourth quarter worth $28,000. Harvest Fund Management Co. Ltd bought a new stake in Healthpeak Properties in the 4th quarter valued at $30,000. Future Financial Wealth Managment LLC purchased a new stake in Healthpeak Properties in the 1st quarter worth $30,000. Covestor Ltd boosted its holdings in shares of Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 1,152 shares during the last quarter. Finally, AdvisorNet Financial Inc grew its position in shares of Healthpeak Properties by 34.5% during the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 563 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.